AAD 2026Abstract 75277
Efficacy and Safety of Ivarmacitinib, a Highly Selective JAK1 Inhibitor, in the Treatment of Non-Segmental Vitiligo
Zheng W
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Pigmentary disorders
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.742 · Not in PubMed: details from Crossref